Eye infection is caused by bacteria, micro-organisms, viruses, and fungi that invade any part of the eye ball and surrounding area which include inner eyelids (conjunctiva), the thin, moist membrane lining the outer eye, and the front surface of the eye (cornea). Eye infections can be the inflammation of the eyelid (blepharitis), conjunctiva (conjunctivitis), the liquid inside the eye (vitritis), the cornea (keratitis), the optic nerve (neuroretinitis) or the retina and the blood vessels that feed it (chorioretinitis). There are numerous symptoms of eye infection such as redness of eyes, pain, light sensitivity, watery eyes, swelling around the eyes, itching of eyes, blurry vision, swollen eyes, and dry eyes.
There are different types of eye infections such as conjunctivitis also known as pink eyes. This infection or inflammation affects the conjunctiva, which is the transparent, thin tissue that covers the external surface of the eye. Endophthalmitis causes inflammation in the intraocular cavity of the eye, including involvement of the vitreous and/or aqueous humour. Endophthalmitis can be chronic (months to years after intraocular surgery), endogenous or post-traumatic (penetrating or perforating ocular injuries). Keratitis is an infection of the cornea that can be caused by Acanthamoeba (a microscopic, waterborne parasite) or the bacteria Staphylococcus aureus and Pseudomonas aeruginosa. Toxoplasmosis of the eye is inflammation of the retina and choroid. Trachoma is one of the leading causes of preventable blindness worldwide. Trachoma is caused by bacterium Chlamydia trachomatis, and leads to repeated conjunctivitis and a mucous discharge. It reduces tears production and causes difficulty in closing the eyelids. This disease is linked to developing countries, due to poor hygiene and crowded living conditions.
The eye infection treatment market is set to expand with the sudden increase in diagnosis and prevalence rate of eye diseases. The market for eye infection treatment is segmented on the basis of product type, distribution channel, and region. Based on product type, the market is majorly segmented as eye drops, gels & creams, and drugs. The drugs segment is further classified into antibiotics, anti-inflammatory, lubricants, and anti-allergens. The generic, low cost competition for some of the drugs and rising prevalence and early diagnosis of eye infections is likely to boost the market in future. Poor personal hygiene
Based on distribution channel, the eye infection treatment market is segmented into hospital pharmacies, retail pharmacies, and E-commerce. Retail pharmacies and hospital pharmacies hold the major share of the eye infection treatment market globally.
Based on geography, the global eye infection treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Geographically, North America was observed to have the largest share of the eye infection treatment market due to better healthcare awareness, high prevalence of disease, and high rate of diagnosis. This was followed by Europe contributing the second largest share to the eye infection treatment market with rising research and development. However, Asian countries are expected to be the fastest growing due to rising awareness, increasing personal care and hygiene, increasing rate of diagnostics, gradual adoption of improved technologies, increasing disposable income, and emerging health care infrastructures. Asia Pacific is followed by Latin America and Middle- East & Africa. Increasing geriatric population is another factor that is expected to boost growth of the eye infection treatment market as the elderly population is at high risk of acquiring the infection.
Some of the major players in the eye infection treatment market are Pfizer, Inc., Valeant Pharmaceuticals Inc., Novartis International AG., Johnson & Johnson, Bausch & Lomb, Inc., Bayer AG, GlaxoSmithKline plc. Merck & Co., Inc., Allergan Inc., and Alcon Laboratories Inc., among several other prominent players.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.